Regulatory actions for June 10, 2026

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.